Comments
Loading...
Gossamer Bio Earnings Estimates, EPS & Revenue | NASDAQ:GOSS | Benzinga
Gossamer Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.190
Quarterly Revenue Estimate
$3.95M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$114.70M
Analyze the earnings history of Gossamer Bio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio | -$0.19 | -$0.19 | — | — | $0.00 | $3.95M | — | — | 05/06/2025 | Get Alert |
| GOSS | Gossamer Bio | -$0.21 | -$0.17 | -$0.15 | 11.76% | $0.00 | $7.02M | $9.38M | 33.60% | 03/13/2025 | Get Alert |
| GOSS | Gossamer Bio | -$0.21 | -$0.15 | -$0.14 | 6.67% | $0.00 | $7.70M | $9.48M | 23.12% | 11/07/2024 | Get Alert |
| GOSS | Gossamer Bio | -$0.45 | $0.23 | $0.22 | -4.35% | $0.00 | $114.29M | $95.84M | -16.14% | 08/12/2024 | Get Alert |
| GOSS | Gossamer Bio | -$0.52 | -$0.18 | -$0.19 | -5.56% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
| GOSS | Gossamer Bio | -$0.59 | -$0.21 | -$0.21 | 0.00% | $0.00 | — | $0.00 | — | 03/05/2024 | Get Alert |
| GOSS | Gossamer Bio | -$0.65 | -$0.26 | -$0.21 | 19.23% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| GOSS | Gossamer Bio | -$0.74 | -$0.49 | -$0.45 | 8.16% | $0.00 | — | $0.00 | — | 08/08/2023 | Get Alert |
| GOSS | Gossamer Bio | -$0.76 | -$0.53 | -$0.52 | 1.89% | $0.00 | — | $0.00 | — | 05/09/2023 | Get Alert |
| GOSS | Gossamer Bio | -$0.74 | -$0.62 | -$0.59 | 4.84% | $0.00 | — | $0.00 | — | 03/17/2023 | Get Alert |
| GOSS | Gossamer Bio | -$0.80 | -$0.63 | -$0.65 | -3.17% | $0.00 | — | $0.00 | — | 11/03/2022 | Get Alert |
| GOSS | Gossamer Bio | -$0.80 | -$0.70 | -$0.74 | -5.71% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| GOSS | Gossamer Bio | -$0.78 | -$0.77 | -$0.76 | 1.30% | $0.00 | — | $0.00 | — | 05/10/2022 | Get Alert |
| GOSS | Gossamer Bio | -$0.88 | -$0.74 | -$0.74 | 0.00% | $0.00 | — | $0.00 | — | 03/03/2022 | Get Alert |
| GOSS | Gossamer Bio | -$0.80 | -$0.78 | -$0.80 | -2.56% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| GOSS | Gossamer Bio | -$1.00 | -$0.76 | -$0.80 | -5.26% | $0.00 | — | $0.00 | — | 08/09/2021 | Get Alert |
| GOSS | Gossamer Bio | -$0.87 | -$0.75 | -$0.78 | -4.00% | $0.00 | — | $0.00 | — | 05/06/2021 | Get Alert |
| GOSS | Gossamer Bio | -$0.89 | -$0.79 | -$0.88 | -11.39% | $0.00 | — | $0.00 | — | 02/25/2021 | Get Alert |
| GOSS | Gossamer Bio | -$0.80 | -$0.85 | -$0.80 | 5.88% | $0.00 | — | $0.00 | — | 11/10/2020 | Get Alert |
| GOSS | Gossamer Bio | -$0.74 | -$0.86 | -$1.00 | -16.28% | $0.00 | — | $0.00 | — | 08/11/2020 | Get Alert |
| GOSS | Gossamer Bio | -$0.90 | -$0.80 | -$0.87 | -8.75% | $0.00 | — | $0.00 | — | 05/12/2020 | Get Alert |
Gossamer Bio (GOSS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.15 | $-0.17 | 11.8 % |
| Q3 | 2024-11-07 | $-0.14 | $-0.15 | 6.67 % |
| Q2 | 2024-08-12 | $0.22 | $0.23 | -4.35 % |
| Q1 | 2024-05-07 | $-0.19 | $-0.18 | -5.56 % |
Gossamer Bio (GOSS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $9.38M | $7.02M | 33.6 % |
| Q3 | 2024-11-07 | $9.48M | $7.70M | 23.1 % |
| Q2 | 2024-08-12 | $95.84M | $114.29M | -16.1 % |
FAQ
When is Gossamer Bio (NASDAQ:GOSS) reporting earnings?
Gossamer Bio (GOSS) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Gossamer Bio (NASDAQ:GOSS)?
The Actual EPS was $-0.15, which beat the estimate of $-0.17.
What were Gossamer Bio’s (NASDAQ:GOSS) revenues?
The Actual Revenue was $9.4M, which beat the estimate of $7M.
Browse earnings estimates, EPS, and revenue on all stocks.